1
|
Capacci E, Bagnoli S, Giacomucci G, Rapillo CM, Govoni A, Bessi V, Polito C, Giotti I, Brogi A, Pelo E, Sorbi S, Nacmias B, Ferrari C. The Frequency of Intermediate Alleles in Patients with Cerebellar Phenotypes. CEREBELLUM (LONDON, ENGLAND) 2024; 23:1135-1145. [PMID: 37906407 PMCID: PMC11102406 DOI: 10.1007/s12311-023-01620-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 10/13/2023] [Indexed: 11/02/2023]
Abstract
Cerebellar syndromes are clinically and etiologically heterogeneous and can be classified as hereditary, neurodegenerative non-hereditary, or acquired. Few data are available on the frequency of each form in the clinical setting. Growing interest is emerging regarding the genetic forms caused by triplet repeat expansions. Alleles with repeat expansion lower than the pathological threshold, termed intermediate alleles (IAs), have been found to be associated with disease manifestation. In order to assess the relevance of IAs as a cause of cerebellar syndromes, we enrolled 66 unrelated Italian ataxic patients and described the distribution of the different etiology of their syndromes and the frequency of IAs. Each patient underwent complete clinical, hematological, and neurophysiological assessments, neuroimaging evaluations, and genetic tests for autosomal dominant cerebellar ataxia (SCA) and fragile X-associated tremor/ataxia syndrome (FXTAS). We identified the following diagnostic categories: 28% sporadic adult-onset ataxia, 18% cerebellar variant of multiple system atrophy, 9% acquired forms, 9% genetic forms with full-range expansion, and 12% cases with intermediate-range expansion. The IAs were six in the FMR1 gene, two in the gene responsible for SCA8, and one in the ATXN2 gene. The clinical phenotype of patients carrying the IAs resembles, in most of the cases, the one associated with full-range expansion. Our study provides an exhaustive description of the causes of cerebellar ataxia, estimating for the first time the frequency of IAs in SCAs- and FXTAS-associated genes. The high percentage of cases with IAs supports further screening among patients with cerebellar syndromes.
Collapse
Affiliation(s)
- Elena Capacci
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy
| | - Silvia Bagnoli
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy
| | - Giulia Giacomucci
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy
| | - Costanza Maria Rapillo
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy
| | - Alessandra Govoni
- Neuromuscular-Skeletal and Sensory Organs Department, AOU Careggi, Florence, Italy
| | - Valentina Bessi
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy
| | | | - Irene Giotti
- SODc Diagnostica Genetica, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
| | - Alice Brogi
- SODc Diagnostica Genetica, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
| | - Elisabetta Pelo
- SODc Diagnostica Genetica, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
| | - Sandro Sorbi
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy
- IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy
| | - Benedetta Nacmias
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy
- IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy
| | - Camilla Ferrari
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
| |
Collapse
|
2
|
Chintalaphani SR, Pineda SS, Deveson IW, Kumar KR. An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics. Acta Neuropathol Commun 2021; 9:98. [PMID: 34034831 PMCID: PMC8145836 DOI: 10.1186/s40478-021-01201-x] [Citation(s) in RCA: 80] [Impact Index Per Article: 26.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Accepted: 05/17/2021] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND Short tandem repeat (STR) expansion disorders are an important cause of human neurological disease. They have an established role in more than 40 different phenotypes including the myotonic dystrophies, Fragile X syndrome, Huntington's disease, the hereditary cerebellar ataxias, amyotrophic lateral sclerosis and frontotemporal dementia. MAIN BODY STR expansions are difficult to detect and may explain unsolved diseases, as highlighted by recent findings including: the discovery of a biallelic intronic 'AAGGG' repeat in RFC1 as the cause of cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS); and the finding of 'CGG' repeat expansions in NOTCH2NLC as the cause of neuronal intranuclear inclusion disease and a range of clinical phenotypes. However, established laboratory techniques for diagnosis of repeat expansions (repeat-primed PCR and Southern blot) are cumbersome, low-throughput and poorly suited to parallel analysis of multiple gene regions. While next generation sequencing (NGS) has been increasingly used, established short-read NGS platforms (e.g., Illumina) are unable to genotype large and/or complex repeat expansions. Long-read sequencing platforms recently developed by Oxford Nanopore Technology and Pacific Biosciences promise to overcome these limitations to deliver enhanced diagnosis of repeat expansion disorders in a rapid and cost-effective fashion. CONCLUSION We anticipate that long-read sequencing will rapidly transform the detection of short tandem repeat expansion disorders for both clinical diagnosis and gene discovery.
Collapse
Affiliation(s)
- Sanjog R. Chintalaphani
- School of Medicine, University of New South Wales, Sydney, 2052 Australia
- Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW 2010 Australia
| | - Sandy S. Pineda
- Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW 2010 Australia
- Brain and Mind Centre, University of Sydney, Camperdown, NSW 2050 Australia
| | - Ira W. Deveson
- Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW 2010 Australia
- Faculty of Medicine, St Vincent’s Clinical School, University of New South Wales, Sydney, NSW 2010 Australia
| | - Kishore R. Kumar
- Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW 2010 Australia
- Molecular Medicine Laboratory and Neurology Department, Central Clinical School, Concord Repatriation General Hospital, University of Sydney, Concord, NSW 2137 Australia
| |
Collapse
|
3
|
Sawada J, Katayama T, Tokashiki T, Kikuchi S, Kano K, Takahashi K, Saito T, Adachi Y, Okamoto Y, Yoshimura A, Takashima H, Hasebe N. The First Case of Spinocerebellar Ataxia Type 8 in Monozygotic Twins. Intern Med 2020; 59:277-283. [PMID: 31554751 PMCID: PMC7008061 DOI: 10.2169/internalmedicine.2905-19] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Spinocerebellar ataxia type 8 (SCA8) is a rare hereditary cerebellar ataxia showing mainly pure cerebellar ataxia. We herein report cases of SCA8 in Japanese monozygotic twins that presented with nystagmus, dysarthria, and limb and truncal ataxia. Their ATXN8OS CTA/CTG repeats were 25/97. They showed similar manifestations, clinical courses, and cerebellar atrophy on magnetic resonance imaging. Some of their pedigrees had nystagmus but not ataxia. These are the first monozygotic twins with SCA8 to be reported anywhere in the world. Although not all subjects with the ATXN8OS CTG expansion develop cerebellar ataxia, these cases suggest the pathogenesis of ATXN8OS repeat expansions in hereditary cerebellar ataxia.
Collapse
Affiliation(s)
- Jun Sawada
- Division of Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan
| | - Takayuki Katayama
- Division of Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan
| | - Takashi Tokashiki
- Department of Neurology, National Hospital Organization Okinawa Hospital, Japan
| | - Shiori Kikuchi
- Division of Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan
| | - Kohei Kano
- Division of Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan
| | - Kae Takahashi
- Division of Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan
| | - Tsukasa Saito
- Division of Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan
| | - Yoshiki Adachi
- Department of Neurology, National Hospital Organization Matsue Medical Center, Japan
| | - Yuji Okamoto
- Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Japan
| | - Akiko Yoshimura
- Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Japan
| | - Hiroshi Takashima
- Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Japan
| | - Naoyuki Hasebe
- Division of Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan
| |
Collapse
|
4
|
Abstract
Spinocerebellar ataxia type 8 (SCA8) is a rare autosomal dominant neurodegenerative disease caused by expanded CTA/CTG repeats in the ATXN8OS gene. Many patients had pure cerebellar ataxia, while some had parkinsonism, both without causal explanation. We analyzed the ATXN8OS gene in 150 Japanese patients with ataxia and 76 patients with Parkinson's disease or related disorders. We systematically reassessed 123 patients with SCA8, both our patients and those reported in other studies. Two patients with progressive supranuclear palsy (PSP) had mutations in the ATXN8OS gene. Systematic analyses revealed that patients with parkinsonism had significantly shorter CTA/CTG repeat expansions and older age at onset than those with predominant ataxia. We show the imaging results of patients with and without parkinsonism. We also found a significant inverse relationship between repeat sizes and age at onset in all patients, which has not been detected previously. Our results may be useful to genetic counseling, improve understanding of the pathomechanism, and extend the clinical phenotype of SCA8.
Collapse
|
5
|
Abstract
The spinocerebellar ataxias (SCAs) are a genetically heterogeneous group of autosomal dominantly inherited progressive disorders, the clinical hallmark of which is loss of balance and coordination accompanied by slurred speech; onset is most often in adult life. Genetically, SCAs are grouped as repeat expansion SCAs, such as SCA3/Machado-Joseph disease (MJD), and rare SCAs that are caused by non-repeat mutations, such as SCA5. Most SCA mutations cause prominent damage to cerebellar Purkinje neurons with consecutive cerebellar atrophy, although Purkinje neurons are only mildly affected in some SCAs. Furthermore, other parts of the nervous system, such as the spinal cord, basal ganglia and pontine nuclei in the brainstem, can be involved. As there is currently no treatment to slow or halt SCAs (many SCAs lead to premature death), the clinical care of patients with SCA focuses on managing the symptoms through physiotherapy, occupational therapy and speech therapy. Intense research has greatly expanded our understanding of the pathobiology of many SCAs, revealing that they occur via interrelated mechanisms (including proteotoxicity, RNA toxicity and ion channel dysfunction), and has led to the identification of new targets for treatment development. However, the development of effective therapies is hampered by the heterogeneity of the SCAs; specific therapeutic approaches may be required for each disease.
Collapse
|
6
|
Vincent JB. Unstable repeat expansion in major psychiatric disorders: two decades on, is dynamic DNA back on the menu? Psychiatr Genet 2017; 26:156-65. [PMID: 27270050 DOI: 10.1097/ypg.0000000000000141] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
For a period in the mid-1990s, soon after the discovery of the involvement of trinucleotide repeat expansions in fragile-X syndrome (both A and E), Huntington's disease, myotonic dystrophy, and a number of hereditary ataxias, there was a clear sense that this new disease mechanism might provide answers for psychiatric disorders. Given the then failures to replicate initial genetic linkage findings for schizophrenia (SCZ) and bipolar disorder (BD), a greater emphasis was placed on the role of complex and non-Mendelian mechanisms, and repeat instability appeared to have the potential to provide adequate explanations for numerous apparently non-Mendelian features such as anticipation, incomplete penetrance, sporadic occurrence, and nonconcordance of monozygotic twins. Initial molecular studies using a ligation-based amplification method (repeat expansion detection) appeared to support the involvement of CAG•CTG repeat expansion in SCZ and BD. However, subsequent studies that dissected the large repeats responsible for much of the positive signal showed that there were three main loci where CAG•CTG repeat expansion was occurring (on 13q21.33, 17q21.33-q22, and 18q21.2). None of the expansions at these loci appeared to segregate with SCZ or BD, and research into repeat expansions in psychiatric illness petered out in the early 2000s. The 13q expansion occurs within a noncoding RNA and appears to be associated with spinocerebellar ataxia 8 (SCA8), but with a still unexplained dichotomy in penetrance - either very high or very low. The 17q expansion occurs within an intron of the carbonic anhydrase-like gene, CA10. The 18q expansion is located within an intron of the TCF4 gene. Mutations in TCF4 are a known cause of Pitt-Hopkins syndrome. Also, pertinently, genome-wide association studies have shown a well-replicated association between TCF4 and SCZ. Two decades on, in 2016, it appears to be an appropriate juncture to reflect on what we have learned, and, with the arrival of newer technologies, whether there is any mileage to be made in revisiting the unstable DNA hypothesis for psychiatric illness.
Collapse
Affiliation(s)
- John B Vincent
- aMolecular Neuropsychiatry & Development (MiND) Lab, Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute bInstitute of Medical Science cDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|
7
|
Koutsis G, Karadima G, Pandraud A, Sweeney MG, Paudel R, Houlden H, Wood NW, Panas M. Genetic screening of Greek patients with Huntington’s disease phenocopies identifies an SCA8 expansion. J Neurol 2013; 259:1874-8. [PMID: 22297462 DOI: 10.1007/s00415-012-6430-9] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2011] [Revised: 01/17/2012] [Accepted: 01/18/2012] [Indexed: 02/06/2023]
Abstract
Huntington’s disease (HD) is an autosomal dominant disorder characterized by a triad of chorea, psychiatric disturbance and cognitive decline. Around 1% of patients with HD-like symptoms lack the causative HD expansion and are considered HD phenocopies. Genetic diseases that can present as HD phenocopies include HD-like syndromes such as HDL1, HDL2 and HDL4 (SCA17), some spinocerebellar ataxias (SCAs) and dentatorubral-pallidoluysian atrophy (DRPLA). In this study we screened a cohort of 21 Greek patients with HD phenocopy syndromes formutations causing HDL2, SCA17, SCA1, SCA2, SCA3,SCA8, SCA12 and DRPLA. Fifteen patients (71%) had a positive family history. We identified one patient (4.8% of the total cohort) with an expansion of 81 combined CTA/CTG repeats at the SCA8 locus. This falls within what is believed to be the high-penetrance allele range. In addition to the classic HD triad, the patient had features of dystonia and oculomotor apraxia. There were no cases of HDL2, SCA17, SCA1, SCA2, SCA3, SCA12 or DRPLA. Given the controversy surrounding the SCA8 expansion, the present finding may be incidental. However, if pathogenic, it broadens the phenotype that may be associated with SCA8 expansions. The absence of any other mutations in our cohort is not surprising, given the low probability of reaching a genetic diagnosis in HD phenocopy patients.
Collapse
Affiliation(s)
- G Koutsis
- Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Ikeda Y, Ranum LPW, Day JW. Clinical and genetic features of spinocerebellar ataxia type 8. HANDBOOK OF CLINICAL NEUROLOGY 2012; 103:493-505. [PMID: 21827909 DOI: 10.1016/b978-0-444-51892-7.00031-0] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- Yoshio Ikeda
- Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN 55455, USA
| | | | | |
Collapse
|
9
|
Marelli C, Cazeneuve C, Brice A, Stevanin G, Dürr A. Autosomal dominant cerebellar ataxias. Rev Neurol (Paris) 2011; 167:385-400. [PMID: 21546047 DOI: 10.1016/j.neurol.2011.01.015] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2010] [Accepted: 01/27/2011] [Indexed: 12/30/2022]
Abstract
Cerebellar ataxias with autosomal dominant transmission (ADCA) are far rarer than sporadic cases of cerebellar ataxia. The identification of genes involved in dominant forms has confirmed the genetic heterogeneity of these conditions and of the underlying mechanisms and pathways. To date, at least 28 genetic loci and, among them, 20 genes have been identified. In many instances, the phenotype is not restricted to cerebellar dysfunction but includes more complex multisystemic neurological deficits. Seven ADCA (SCA1, 2, 3, 6, 7, 17, and dentatorubro-pallido-luysian atrophy) are caused by repeat expansions in the corresponding proteins; phenotype-genotype correlations have shown that repeat size influences the progression of the disease, its severity and clinical differences among patients, including the phenomenon of anticipation between generations. All other ADCA are caused either by non-coding repeat expansions, conventional mutations or large rearrangements in genes with different functions. This review will focus on the genetic features of ADCA and on the clinical differences among the different forms.
Collapse
Affiliation(s)
- C Marelli
- Département de génétique et cytogénétique, consultation de génétique clinique, CHU Pitié-Salpêtrière, AP-HP, 47, boulevard de l'Hôpital, 75013 Paris, France
| | | | | | | | | |
Collapse
|
10
|
Abstract
Cerebellar ataxias with autosomal dominant transmission are rare, but identification of the associated genes has provided insight into the mechanisms that could underlie other forms of genetic or non-genetic ataxias. In many instances, the phenotype is not restricted to cerebellar dysfunction but includes complex multisystemic neurological deficits. The designation of the loci, SCA for spinocerebellar ataxia, indicates the involvement of at least two systems: the spinal cord and the cerebellum. 11 of 18 known genes are caused by repeat expansions in the corresponding proteins, sharing the same mutational mechanism. All other SCAs are caused by either conventional mutations or large rearrangements in genes with different functions, including glutamate signalling (SCA5/SPTBN2) and calcium signalling (SCA15/16/ITPR1), channel function (SCA13/KCNC3, SCA14/PRKCG, SCA27/FGF14), tau regulation (SCA11/TTBK2), and mitochondrial activity (SCA28/AFG3L2) or RNA alteration (SCA31/BEAN-TK2). The diversity of underlying mechanisms that give rise to the dominant cerebellar ataxias need to be taken into account to identify therapeutic targets.
Collapse
Affiliation(s)
- Alexandra Durr
- Université Pierre et Marie Curie-Paris, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière, UMR-S975, Paris, France.
| |
Collapse
|
11
|
Gupta A, Jankovic J. Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. Parkinsonism Relat Disord 2009; 15:621-6. [PMID: 19559641 DOI: 10.1016/j.parkreldis.2009.06.001] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/09/2009] [Revised: 06/01/2009] [Accepted: 06/02/2009] [Indexed: 12/16/2022]
Abstract
Spinocerebellar ataxia 8 (SCA8), a triplet repeat expansion disorder, is genetically distinct from the other inherited ataxias, but its unusually variable phenotype can make its diagnosis difficult. In this review we describe 3 new cases of genetically verified SCA8 to highlight the broad clinical spectrum of symptoms observed with this disorder and to draw attention to the features of myoclonus and migraine headaches, which in the context of cerebellar ataxia warrants the clinician to consider SCA8 as a potential diagnosis. We also address the controversy surrounding the genetic testing approach for diagnosing SCA8. Finally, we evaluate the evidence that SCA8 may affect calcium channel function and that the presentation of episodic ataxia and migraines suggests a clinical and pathogenic overlap of SCA8 with the channelopathies.
Collapse
Affiliation(s)
- Amitabh Gupta
- Department of Neurology, University of Toronto, Toronto, ON, Canada M5T 2S8
| | | |
Collapse
|
12
|
Abstract
Magnetic resonance (MR) imaging is widely used to visualize atrophic processes that occur during the pathogenesis of spinocerebellar ataxias (SCAs). T1-weighted images are utilized to rate the atrophy of cerebellar vermis, cerebellar hemispheres, pons and midbrain. Signal changes in the basal ganglia and ponto-cerebellar fibers are evaluated by T2-weighted and proton density-weighted images. However, two-dimensional (2D) images do not allow a reliable quantification of the degree of atrophy. The latter is now possible through the application of three-dimensional (3D) true volumetric methods, which should be used for research purposes. Ideally, these methods should allow automated segmentation of contrast-defined boundaries by using region growing algorithms, which can be applied successfully in structures of the posterior fossa and basal ganglia. Thin slice thickness helps to minimize partial volume effects. Whereas volumetric approaches rely on predetermined anatomical boundaries, voxel-based morphometry has been developed to determine group differences between different types of SCA (cross-sectional studies) or within one SCA entity (longitudinal studies). We will review recent results and how these methods are currently used to (i) separate sporadic and dominantly inherited forms of cerebellar ataxias; (ii) identify specific SCA genotypes; (iii) correlate patho-anatomical changes with SCA disease symptoms or severity; and (iv) visualize and estimate the rate of progression in SCA.
Collapse
|
13
|
SCA8 repeat expansion: large CTA/CTG repeat alleles in neurological disorders and functional implications. Hum Genet 2009; 125:437-44. [PMID: 19229559 DOI: 10.1007/s00439-009-0641-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2009] [Accepted: 02/10/2009] [Indexed: 12/15/2022]
Abstract
Spinocerebellar ataxia type 8 (SCA8) involves bidirectional expression of CUG (ATXN8OS) and CAG (ATXN8) expansion transcripts. The pathogenesis of SCA8 is complex and the spectrum of clinical presentations is broad. In the present study, we assessed the SCA8 repeat size ranges in Taiwanese Parkinson's disease, Alzheimer's disease and atypical parkinsonism and investigated the genetic variation modulating ATXN8 expression. Thirteen large SCA8 alleles and a novel ATXN8 -62 G/A promoter SNP were found. There is a significant difference in the proportion of the individuals carrying SCA8 larger alleles in atypical parkinsonism (P = 0.044) as compared to that in the control subjects. In lymphoblastoid cells carrying SCA8 large alleles, treatment of MG-132 or staurosporine significantly increases the cell death or caspase 3 activity. Although expressed at low steady-state, ATXN8 expression level is significantly higher (P = 0.012) in cells with SCA8 large alleles than that of the control cells. The ATXN8 transcriptional activity was significantly higher in the luciferase reporter construct containing the -62G allele than that containing the -62A allele in both neuroblastoma and embryonic kidney cells. Therefore, our preliminary results suggest that ATXN8 gene -62 G/A polymorphism may be functional in modulating ATXN8 expression.
Collapse
|
14
|
Chen IC, Lin HY, Lee GC, Kao SH, Chen CM, Wu YR, Hsieh-Li HM, Su MT, Lee-Chen GJ. Spinocerebellar ataxia type 8 larger triplet expansion alters histone modification and induces RNA foci. BMC Mol Biol 2009; 10:9. [PMID: 19203395 PMCID: PMC2647542 DOI: 10.1186/1471-2199-10-9] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2008] [Accepted: 02/10/2009] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND Spinocerebellar ataxia type 8 (SCA8) involves the expression of an expanded CTG/CAG combined repeats (CR) from opposite strands producing CUG expansion transcripts (ataxin 8 opposite strand, ATXN8OS) and a polyglutamine expansion protein (ataxin 8, ATXN8). The pathogenesis of SCA8 is complex and the spectrum of clinical presentations is broad. RESULTS Using stably induced cell models expressing 0, 23, 88 and 157 CR, we study the role of ATXN8OS transcripts in SCA8 pathogenesis. In the absence of doxycycline, the stable ATXN8OS CR cell lines exhibit low levels of ATXN8OS expression and a repeat length-related increase in staurosporine sensitivity and in the number of annexin positive cells. A repeat length-dependent repression of ATXN8OS expression was also notable. Addition of doxycycline leads to 25 approximately 50 times more ATXN8OS RNA expression with a repeat length-dependent increase in fold of ATXN8OS RNA induction. ChIP-PCR assay using anti-dimethyl-histone H3-K9 and anti-acetyl-histone H3-K14 antibodies revealed increased H3-K9 dimethylation and reduced H3-K14 acetylation around the ATXN8OS cDNA gene in 157 CR line. The repeat length-dependent increase in induction fold is probably due to the increased RNA stability as demonstrated by monitoring ATXN8OS RNA decay in cells treated with the transcriptional inhibitor, actinomycin D. In cells stably expressing ATXN8OS, RNA FISH experiments further revealed ribonuclear foci formation in cells carrying expanded 88 and 157 CR. CONCLUSION The present study demonstrates that the expanded CUG-repeat tracts are toxic to human cells and may affect ATXN8OS RNA expression and stability through epigenetic and post-transcriptional mechanisms.
Collapse
Affiliation(s)
- I-Cheng Chen
- Department of Life Science, National Taiwan Normal University, Taipei 116, Taiwan
| | - Hsuan-Yuan Lin
- Department of Life Science, National Taiwan Normal University, Taipei 116, Taiwan
| | - Ghin-Chueh Lee
- Department of Life Science, National Taiwan Normal University, Taipei 116, Taiwan
| | - Shih-Huan Kao
- Department of Life Science, National Taiwan Normal University, Taipei 116, Taiwan
| | - Chiung-Mei Chen
- Department of Neurology, Chang Gung Memorial Hospital, Chang-Gung University College of Medicine, Taipei 105, Taiwan
| | - Yih-Ru Wu
- Department of Neurology, Chang Gung Memorial Hospital, Chang-Gung University College of Medicine, Taipei 105, Taiwan
| | - Hsiu-Mei Hsieh-Li
- Department of Life Science, National Taiwan Normal University, Taipei 116, Taiwan
| | - Ming-Tsan Su
- Department of Life Science, National Taiwan Normal University, Taipei 116, Taiwan
| | - Guey-Jen Lee-Chen
- Department of Life Science, National Taiwan Normal University, Taipei 116, Taiwan
| |
Collapse
|
15
|
Genetics and Pathogenesis of Inherited Ataxias and Spastic Paraplegias. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2009; 652:263-96. [DOI: 10.1007/978-90-481-2813-6_18] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
16
|
Munhoz RP, Teive HA, Raskin S, Werneck LC. CTA/CTG expansions at the SCA 8 locus in multiple system atrophy. Clin Neurol Neurosurg 2008; 111:208-10. [PMID: 18980793 DOI: 10.1016/j.clineuro.2008.09.003] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2008] [Revised: 08/29/2008] [Accepted: 09/05/2008] [Indexed: 10/21/2022]
Abstract
OBJECTIVE Spinocerebellar ataxia type 8 (SCA 8) is an autosomal dominant disorder characterized by cerebellar ataxia with additional features, such as upper motor neuron signs, urinary incontinence and dysphagia. From a clinical standpoint, SCA 8 and the cerebellar form of multiple system atrophy (MSA-C) share several common features. METHODS We studied the presence of expanded SCA 8 alleles in 10 sporadic patients with probable MSA-C. RESULTS We found 1 patient with a heterozygous CTA/CTG repeat expansion in the pathological range. Clinically this subject presented no features that differed from the other subjects carrying smaller repeat sizes. CONCLUSIONS We believe that the association of SCA 8 repeat expansions with sporadic, atypical and heterogeneous phenotypes is debatable and should be interpreted with caution. Our personal conclusion is that testing in such patients may become a source of diagnostic confusion.
Collapse
Affiliation(s)
- Renato P Munhoz
- Department of Neurology, Hospital de Clínicas, Federal University of Paraná, Curitiba, PR, Brazil.
| | | | | | | |
Collapse
|
17
|
Torrens L, Burns E, Stone J, Graham C, Wright H, Summers D, Sellar R, Porteous M, Warner J, Zeman A. Spinocerebellar ataxia type 8 in Scotland: frequency, neurological, neuropsychological and neuropsychiatric findings. Acta Neurol Scand 2008; 117:41-8. [PMID: 18095954 DOI: 10.1111/j.1600-0404.2007.00904.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVES The objectives of this study were to: (i) establish whether the spinocerebellar ataxia type 8 (SCA 8) expansion is associated with ataxia in Scotland; (ii) test the hypothesis that SCA 8 is associated with neuropsychological impairment; and (iii) review neuroradiological findings in SCA 8. METHODS The methods included: (i) measurement of SCA 8 expansion frequencies in ataxic patients and healthy controls; (ii) comprehensive neuropsychological assessment of patients with SCA 8 and matched controls, neuropsychiatric interview; and (iii) comparison of patient and matched control magnetic resonance imaging (MRI) scans. RESULTS (i) 10/694 (1.4%) unrelated individuals with ataxia had combined CTA/CTG repeat expansions >100 compared to 1/1190 (0.08%) healthy controls (P < 0.0005); (ii) neuropsychological assessment revealed a dysexecutive syndrome among SCA 8 patients, not readily explained by motor or mood disturbance; neuropsychiatric symptoms occurred commonly; (iii) cerebellar atrophy was the only salient MRI abnormality in the patient group. CONCLUSIONS The SCA 8 expansion is associated with ataxia in Scotland. The disorder is associated with a dysexecutive syndrome.
Collapse
Affiliation(s)
- L Torrens
- The Robert Fergusson Unit, Royal Edinburgh Hospital, Edinburgh, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Sáfrány E, Balikó L, Guseo A, Faragó B, Melegh B. The autosomal dominant cerebellar ataxias are hereditary neurodegenerative diseases. Orv Hetil 2007; 148:2125-32. [DOI: 10.1556/oh.2007.28205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Az autoszomális domináns cerebellaris ataxiák örökletes neurodegeneratív betegségek. Az ataxiák még néhány évtizeddel ezelőtt is a legkevésbé megértett idegi rendellenességek közé tartoztak, de molekuláris hátterük tisztázása mára lehetőséget teremtett a pontos diagnózis megállapítására, és segítséget nyújtott számos olyan különös jelenség értelmezésében is, mint például a családon belül változatosan megjelenő fenotípus. A spinocerebellaris ataxiák patogenezisének megismerése esélyt kínálhat sikeres terápiák kifejlesztésére, a jelenlegi, pusztán tüneti kezelések helyett. A gyors egymásutánban felfedezett gének és génlocusok, valamint a kialakított ataxiaaltípusok azonban zavart is okozhatnak a betegség pontos meghatározásában. Célunk rövid betekintést nyújtani e neurodegeneratív kórképek genetikai hátterébe, és a fontosabb ataxiaaltípusok jellemzésével megkönnyíteni az egyértelmű diagnózis felállítását.
Collapse
Affiliation(s)
- Enikő Sáfrány
- 1 Pécsi Tudományegyetem, Általános Orvostudományi Kar Orvosi Genetikai és Gyermekfejlődéstani Intézet Pécs Szigeti út 12. 7624
| | - László Balikó
- 2 Veszprém Megyei Csolnoky Ferenc Kórház Neurológiai és Stroke Osztály Veszprém
| | - András Guseo
- 3 Fejér Megyei Szent György Kórház Neurológiai Osztály Székesfehérvár
| | - Bernadett Faragó
- 1 Pécsi Tudományegyetem, Általános Orvostudományi Kar Orvosi Genetikai és Gyermekfejlődéstani Intézet Pécs Szigeti út 12. 7624
| | - Béla Melegh
- 1 Pécsi Tudományegyetem, Általános Orvostudományi Kar Orvosi Genetikai és Gyermekfejlődéstani Intézet Pécs Szigeti út 12. 7624
| |
Collapse
|
19
|
|
20
|
Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS, Chen G, Weatherspoon MR, Clark HB, Ebner TJ, Day JW, Ranum LPW. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 2006; 38:758-69. [PMID: 16804541 DOI: 10.1038/ng1827] [Citation(s) in RCA: 316] [Impact Index Per Article: 17.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2006] [Accepted: 05/22/2006] [Indexed: 11/08/2022]
Abstract
We previously reported that a (CTG)n expansion causes spinocerebellar ataxia type 8 (SCA8), a slowly progressive ataxia with reduced penetrance. We now report a transgenic mouse model in which the full-length human SCA8 mutation is transcribed using its endogenous promoter. (CTG)116 expansion, but not (CTG)11 control lines, develop a progressive neurological phenotype with in vivo imaging showing reduced cerebellar-cortical inhibition. 1C2-positive intranuclear inclusions in cerebellar Purkinje and brainstem neurons in SCA8 expansion mice and human SCA8 autopsy tissue result from translation of a polyglutamine protein, encoded on a previously unidentified antiparallel transcript (ataxin 8, ATXN8) spanning the repeat in the CAG direction. The neurological phenotype in SCA8 BAC expansion but not BAC control lines demonstrates the pathogenicity of the (CTG-CAG)n expansion. Moreover, the expression of noncoding (CUG)n expansion transcripts (ataxin 8 opposite strand, ATXN8OS) and the discovery of intranuclear polyglutamine inclusions suggests SCA8 pathogenesis involves toxic gain-of-function mechanisms at both the protein and RNA levels.
Collapse
Affiliation(s)
- Melinda L Moseley
- Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Kraft S, Furtado S, Ranawaya R, Parboosingh J, Bleoo S, McElligott K, Bridge P, Spacey S, Das S, Suchowersky O. Adult onset spinocerebellar ataxia in a Canadian movement disorders clinic. Can J Neurol Sci 2006; 32:450-8. [PMID: 16408574 DOI: 10.1017/s0317167100004431] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
BACKGROUND The spinocerebellar ataxias (SCAs) are a genetically and clinically heterogeneous group of neurodegenerative disorders. Relative frequencies vary within different ethnic groups and geographical locations. OBJECTIVES 1) To determine the frequencies of hereditary and sporadic adult onset SCAs in the Movement Disorders population; 2) to assess if the fragile X mental retardation gene 1 (FMR1) premutation is found in this population. METHODS A retrospective chart review of individuals with a diagnosis of adult onset SCA was carried out. Testing for SCA types 1, 2, 3, 6, 7, and 8, Dentatorubral-pallidoluysian atrophy (DRPLA), Friedreich ataxia and the FMR1 expansion was performed. RESULTS A total of 69 patients in 60 families were identified. Twenty-one (35%) of the families displayed autosomal dominant and two (3.3%) showed autosomal recessive (AR) pattern of inheritance. A positive but undefined family history was noted in nine (15%). The disorder appeared sporadic in 26 patients (43.3%). In the AD families, the most common mutation was SCA3 (23.8%) followed by SCA2 (14.3%) and SCA6 (14.3%). The SCA1 and SCA8 were each identified in 4.8%. FA was found in a pseudodominant pedigree, and one autosomal recessive pedigree. One sporadic patient had a positive test (SCA3).Dentatorubral-pallidoluysian atrophy and FMR1 testing was negative. CONCLUSION A positive family history was present in 53.3% of our adult onset SCA patients. A specific genetic diagnosis could be given in 61.9% of dominant pedigrees with SCA3 being the most common mutation, followed by SCA2 and SCA6. The yield in sporadic cases was low. The fragile X premutation was not found to be responsible for SCA.
Collapse
Affiliation(s)
- Scott Kraft
- Movement Disorsders program, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
| | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Maschke M, Oehlert G, Xie TD, Perlman S, Subramony SH, Kumar N, Ptacek LJ, Gomez CM. Clinical feature profile of spinocerebellar ataxia type 1-8 predicts genetically defined subtypes. Mov Disord 2006; 20:1405-12. [PMID: 16037936 DOI: 10.1002/mds.20533] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
An increasing number of genetically defined types of spinocerebellar ataxia (SCA) have been reported in the past decade. Phenotype--genotype correlation studies have suggested a broad overlap between SCA types. The aim of the present study was to identify patterns of clinical features that were likely to distinguish between SCA types and to test the specificity and sensitivity of these signs and symptoms using a Bayesian classifier. In total, 127 patients from 50 families with SCA types 1 to 8 were examined using a worksheet with a panel of 33 symptoms and signs. By computing the probabilities of each trait for each SCA type, we rated the predictive value of each feature for each form of ataxia and then combined the probabilities for the entire panel of traits to construct a Bayesian classifier. Results of this analysis were summarized in a simpler, more operator-based algorithm. Patients with SCA5, SCA6, and SCA8 demonstrated a predominant cerebellar syndrome, whereas patients with SCA1, SCA2, SCA3, SCA4, and SCA7 frequently had clinical features indicating an extracerebellar involvement. The Bayesian classifier predicted the SCA type in 78% of patients with sensitivities between 60 and 100% and specificities between 94 and 98.2%. The highest sensitivity to correctly predict the true SCA type was found for SCA5, SCA7, and SCA8. Sensitivities and specificities found in the present study validate the use of algorithms to help to prioritize specific SCA gene testing, which will help to reduce costs for gene testing.
Collapse
Affiliation(s)
- Matthias Maschke
- Department of Neurology, University of Duisburg-Essen, Essen, Germany
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Kerber KA, Jen JC, Perlman S, Baloh RW. Late-onset pure cerebellar ataxia: Differentiating those with and without identifiable mutations. J Neurol Sci 2005; 238:41-5. [PMID: 16109427 DOI: 10.1016/j.jns.2005.06.006] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2005] [Accepted: 06/09/2005] [Indexed: 11/23/2022]
Abstract
Late onset cerebellar ataxia can be caused by several genetic mutations but a large percentage of patients remain undiagnosed. Thirty-eight patients with onset of slowly progressive, pure cerebellar ataxia >or=40 years-of-age were identified from a large ataxia database. Their clinical findings and quantitative oculomotor tests were reviewed; all were screened for SCA1, SCA2, SCA3, SCA6, SCA8, SCA14, and the Fragile X premutation (FMR1). All 47 exons of CACNA1A were screened for mutations. Genetic analysis uncovered a mutation in 11 patients. The SCA6 mutation was present in 8 patients (repeats 22-23). Three additional genetic mutations were found: SCA1 (42 repeats), SCA3 (66 repeats), and SCA8 (121 repeats). Patients without identified genetic mutations were characterized by 1) a later age of onset, 2) truncal without extremity ataxia, 3) and down beat nystagmus. Although only a third of these idiopathic late onset ataxia patients had a positive family history, this homogeneous syndrome probably represents a yet to be identified genetic disorder.
Collapse
Affiliation(s)
- Kevin A Kerber
- Department of Neurology, UCLA School of Medicine, Los Angeles, CA, USA
| | | | | | | |
Collapse
|
24
|
Felling RJ, Barron TF. Early onset of ataxia in a child with a pathogenic SCA8 allele. Pediatr Neurol 2005; 33:136-8. [PMID: 16087061 DOI: 10.1016/j.pediatrneurol.2005.02.010] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/29/2004] [Revised: 01/08/2005] [Accepted: 02/14/2005] [Indexed: 10/25/2022]
Abstract
This case report describes a child with an expanded CTA/CTG repeat in one allele of the spinocerebellar ataxia 8 gene. This patient presented with ataxia at a much earlier age than is typical for patients with this condition. This unique patient further highlights the complexity of the role that this molecular defect plays in the onset and course of the disease.
Collapse
Affiliation(s)
- Ryan J Felling
- Penn State University College of Medicine, Neural and Behavioral Sciences, Hershey, Pennsylvania 17033, USA
| | | |
Collapse
|
25
|
Factor SA, Qian J, Lava NS, Hubbard JD, Payami H. False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy. Ann Neurol 2005; 57:462-3. [PMID: 15732096 DOI: 10.1002/ana.20389] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
26
|
Corral J, Genís D, Banchs I, San Nicolás H, Armstrong J, Volpini V. Giant SCA8 alleles in nine children whose mother has two moderately large ones. Ann Neurol 2005; 57:549-53. [PMID: 15786481 DOI: 10.1002/ana.20421] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
We report here a family in which each of nine children has inherited giant SCA8 CTG expansions from a homozygous mother who has two moderately large SCA8 CTG alleles. In contrast, three homozygous male individuals and a case of coexistence of two expansions of the FRDA gene and one of SCA8, all of them with moderately large alleles, have transmitted their respective SCA8 expanded alleles with minor changes, as usually occurs in heterozygous male transmissions.
Collapse
Affiliation(s)
- Jordi Corral
- Centre de Genètica Mèdica i Molecular-Institut de Recerca Oncològica-IDIBELL, Hospital Duran i Reynals, Barcelona, Spain
| | | | | | | | | | | |
Collapse
|
27
|
Subramony SH. GENETICS OF INHERITED ATAXIAS. Continuum (Minneap Minn) 2005. [DOI: 10.1212/01.con.0000293702.31088.0d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
28
|
Wernovsky G, Shillingford AJ, Gaynor JW. Central nervous system outcomes in children with complex congenital heart disease. Curr Opin Cardiol 2005; 20:94-9. [PMID: 15711194 DOI: 10.1097/01.hco.0000153451.68212.68] [Citation(s) in RCA: 117] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
PURPOSE OF REVIEW To provide a brief overview of our current understanding of the types of neurodevelopmental sequelae in congenital heart disease survivors and to review the most recent studies from the past year, which have focused on 4 interrelated issues: (1) outcome studies, (2) the mechanism and etiology of central nervous system injury in children with CHD, (3) perioperative monitoring for brain injury, and (4) strategies for neuroprotection during cardiac surgery. RECENT FINDINGS As the number of survivors of surgery for complex congenital heart disease continues to rise, it is recognized that there is an increased incidence of adverse neurological outcomes in the survivors. In particular, a pattern similar to that seen in premature infants is emerging, including learning disabilities, behavioral abnormalities, inattention and hyperactivity. Imaging studies have revealed a high prevalence of structural brain abnormalities and periventricular leukomalacia, fetal and postnatal cerebral blood flow is abnormal, postnatal oxygen delivery is decreased, and intraoperative support techniques and postoperative low cardiac output are associated with cerebral hypoperfusion. SUMMARY The causes of these late developmental abnormalities are most likely sequential, cumulative and multifactorial.
Collapse
Affiliation(s)
- Gil Wernovsky
- Division of Pediatric Cardiology, The Children's Hospital of Philadelphia, Pennsylvania 19104, USA.
| | | | | |
Collapse
|
29
|
Ikeda Y, Dalton JC, Moseley ML, Gardner KL, Bird TD, Ashizawa T, Seltzer WK, Pandolfo M, Milunsky A, Potter NT, Shoji M, Vincent JB, Day JW, Ranum LPW. Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet 2004; 75:3-16. [PMID: 15152344 PMCID: PMC1182005 DOI: 10.1086/422014] [Citation(s) in RCA: 71] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2004] [Accepted: 04/05/2004] [Indexed: 11/03/2022] Open
Abstract
We reported elsewhere that an untranslated CTG expansion causes the dominantly inherited neurodegenerative disorder spinocerebellar ataxia type 8 (SCA8). SCA8 shows a complex inheritance pattern with extremes of incomplete penetrance, in which often only one or two affected individuals are found in a given family. SCA8 expansions have also been found in control chromosomes, indicating that separate genetic or environmental factors increase disease penetrance among SCA8-expansion-carrying patients with ataxia. We describe the molecular genetic features and disease penetrance of 37 different families with SCA8 ataxia from the United States, Canada, Japan, and Mexico. Haplotype analysis using 17 STR markers spanning an approximately 1-Mb region was performed on the families with ataxia, on a group of expansion carriers in the general population, and on psychiatric patients, to clarify the genetic basis of the reduced penetrance and to investigate whether CTG expansions among different populations share a common ancestral background. Two major ancestrally related haplotypes (A and A') were found among white families with ataxia, normal controls, and patients with major psychosis, indicating a common ancestral origin of both pathogenic and nonpathogenic SCA8 expansions among whites. Two additional and distinct haplotypes were found among a group of Japanese families with ataxia (haplotype B) and a Mexican family with ataxia (haplotype C). Our finding that SCA8 expansions on three independently arising haplotypes are found among patients with ataxia and cosegregate with ataxia when multiple family members are affected further supports the direct role of the CTG expansion in disease pathogenesis.
Collapse
Affiliation(s)
- Yoshio Ikeda
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - Joline C. Dalton
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - Melinda L. Moseley
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - Kathy L. Gardner
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - Thomas D. Bird
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - Tetsuo Ashizawa
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - William K. Seltzer
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - Massimo Pandolfo
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - Aubrey Milunsky
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - Nicholas T. Potter
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - Mikio Shoji
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - John B. Vincent
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - John W. Day
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| | - Laura P. W. Ranum
- Institute of Human Genetics and Departments of Genetics, Cell Biology, and Development and Neurology, University of Minnesota, Minneapolis; Veterans Administration Hospital Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh; Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology, University of Texas Medical Branch, Galveston, TX; Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston; Athena Diagnostics, Worcester, MA; Department of Neurology, Erasme Hospital, Brussels Free University, Brussels; Center for Human Genetics, Boston University School of Medicine, Boston; Department of Medical Genetics, University of Tennessee Medical Center, Knoxville, TN; Department of Neurology, Division of Neuroscience, Biophysical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and Neurogenetics Section, The Centre for Addiction and Mental Health, Toronto
| |
Collapse
|
30
|
Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004; 3:291-304. [PMID: 15099544 DOI: 10.1016/s1474-4422(04)00737-9] [Citation(s) in RCA: 666] [Impact Index Per Article: 33.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Autosomal dominant cerebellar ataxias are hereditary neurodegenerative disorders that are known as spinocerebellar ataxias (SCA) in genetic nomenclature. In the pregenomic era, ataxias were some of the most poorly understood neurological disorders; the unravelling of their molecular basis enabled precise diagnosis in vivo and explained many clinical phenomena such as anticipation and variable phenotypes even within one family. However, the discovery of many ataxia genes and loci in the past decade threatens to cause more confusion than optimism among clinicians. Therefore, the provision of guidance for genetic testing according to clinical findings and frequencies of SCA subtypes in different ethnic groups is a major challenge. The identification of ataxia genes raises hope that essential pathogenetic mechanisms causing SCA will become more and more apparent. Elucidation of the pathogenesis of SCA hopefully will enable the development of rational therapies for this group of disorders, which currently can only be treated symptomatically.
Collapse
Affiliation(s)
- Ludger Schöls
- Department of Neurology, University of Tuebingen, Germany
| | | | | | | | | |
Collapse
|
31
|
Abstract
Cerebrovascular disorders are an important cause of mortality and chronic morbidity in children. International incidence rates for childhood stroke (ie, from 30 days to 18 years of age) have ranged from 1.3 to 13 per 100,000 children. Ischemic stroke is probably more common than hemorrhagic stroke in children. The clinical presentation of stroke in children varies according to age and location of the stroke. Over 100 risk factors for stroke in children have been reported, but in up to one third of cases no cause is identified. The management and prevention of stroke in children is not well studied and current recommendations are based on adult studies, nonrandomized trials, or expert opinion. Over half of children with stroke will develop lifelong cognitive or motor disability and up to one third will have a recurrent stroke. This review briefly describes the epidemiology, risk factors, evaluation, treatment, and outcome of stroke in children.
Collapse
Affiliation(s)
- John Kylan Lynch
- Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, NIH/DHHS, Building 10, Room 5S220, 10 Center Drive, MSC 1447, Bethesda, MD 20892-1447, USA.
| |
Collapse
|
32
|
Mutsuddi M, Marshall CM, Benzow KA, Koob MD, Rebay I. The Spinocerebellar Ataxia 8 Noncoding RNA Causes Neurodegeneration and Associates with Staufen in Drosophila. Curr Biol 2004; 14:302-8. [PMID: 14972680 DOI: 10.1016/j.cub.2004.01.034] [Citation(s) in RCA: 123] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2003] [Revised: 12/18/2003] [Accepted: 12/29/2003] [Indexed: 11/29/2022]
Abstract
Spinocerebellar Ataxia 8 (SCA8) appears unique among triplet repeat expansion-induced neurodegenerative diseases because the predicted gene product is a noncoding RNA. Little is currently known about the normal function of SCA8 in neuronal survival or how repeat expansion contributes to neurodegeneration. To investigate the molecular context in which SCA8 operates, we have expressed the human SCA8 noncoding RNA in Drosophila. SCA8 induces late-onset, progressive neurodegeneration in the Drosophila retina. Using this neurodegenerative phenotype as a sensitized background for a genetic modifier screen, we have identified mutations in four genes: staufen, muscle-blind, split ends, and CG3249. All four encode neuronally expressed RNA binding proteins conserved in Drosophila and humans. Although expression of both wild-type and repeat-expanded SCA8 induce neurodegeneration, the strength of interaction with certain modifiers differs between the two SCA8 backgrounds, suggesting that CUG expansions alter associations with specific RNA binding proteins. Our demonstration that SCA8 can recruit Staufen and that the interaction domain maps to the portion of the SCA8 RNA that undergoes repeat expansion in the human disease suggests a specific mechanism for SCA8 function and disease. Genetic modifiers identified in our SCA8-based screens may provide candidates for designing therapeutic interventions to treat this disease.
Collapse
Affiliation(s)
- Mousumi Mutsuddi
- Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA
| | | | | | | | | |
Collapse
|
33
|
Abstract
UNLABELLED PURPOSE OF REVIEW Childhood: stroke is more common than brain tumor, but because there is a wide spectrum in terms of etiology and most centers see only a few cases every year, there have been few large studies of genetic and environmental risk factors until recently. This review focuses on the clinical and radiologic methodology required to distinguish phenotypes in patients, and it focuses on the available data on genetic predisposition. RECENT FINDINGS A number of conditions with Mendelian inheritance (eg, sickle cell disease) predispose to childhood stroke, but the search for epistatic polymorphisms that explain why some but not all of these patients are affected has been hampered by our poor understanding of the pathophysiology. Emergency vascular imaging, including arteriography and venography, will almost certainly assist with the description of stroke subtypes with different genetic predisposition in these patients and in the important group of children who were completely healthy before their stroke. Environmental exposure (eg, to infection, hypoxemia, and vitamins) may play a crucial role in modifying genetic expression and must be described carefully in prospective studies. SUMMARY Now that much of the work on classifying stroke subtypes in children has been undertaken, international collaboration is likely to lead to identification of the genetic and environmental risk factors, and thus to primary and secondary prevention.
Collapse
Affiliation(s)
- Fenella J Kirkham
- Institute of Child Health, University College London and Southampton General Hospital, London, United Kingdom.
| |
Collapse
|
34
|
|